Abstract
The effect of the α-glucosidase inhibitor acarbose on metabolic control was studied in insulin-dependent diabetics who were accustomed to home monitoring of blood glucose levels and to adapting their insulin dose. Following informed consent 20 patients took part in the 4-week run-in period under placebo treatment. Thereafter they were treated for 8 weeks with thrice-daily 100 mg acarbose po; this was followed by another 4-week placebo treatment.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Hulst, S.G.T., Spooren, P.F.J.M., Smith, P.A., Hulk, T. (1988). Acarbose in Insulin-Dependent Diabetes Mellitus: Efficacy and Tolerance. In: Creutzfeldt, W. (eds) Acarbose for the Treatment of Diabetes Mellitus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73583-7_55
Download citation
DOI: https://doi.org/10.1007/978-3-642-73583-7_55
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-19145-2
Online ISBN: 978-3-642-73583-7
eBook Packages: Springer Book Archive